Adverse Events: Elevidys (Delandistrogene Moxeparvovec)

This product provides a detailed summary of adverse events related to the use of Elevidys (Delandistrogene Moxeparvovec), based on reports submitted to the FDA Adverse Event Reporting System (FAERS). The data highlights incidents linked to this drug, offering insights into potential safety concerns.

Please note that the dataset includes only adverse events recorded in FAERS and may contain duplicate reports, where multiple entries could refer to the same event. This comprehensive report is useful for monitoring drug safety and assessing potential risks associated with Elevidys.